Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2012-10-01
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 298
- Registration Number
- NCT00895011
- Locations
- 🇺🇸
Research Site, Richmond, Virginia, United States
Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction
- First Posted Date
- 2009-03-02
- Last Posted Date
- 2012-08-17
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 712
- Registration Number
- NCT00853606
- Locations
- 🇺🇸
Research Site, Spring, Texas, United States
A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.
Phase 1
Completed
- Conditions
- Obesity
- First Posted Date
- 2009-02-12
- Last Posted Date
- 2010-01-21
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 20
- Registration Number
- NCT00842400
- Locations
- 🇺🇸
MDS Pharma Services, Phoenix, Arizona, United States
A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2010-01-21
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 112
- Registration Number
- NCT00839891
- Locations
- 🇺🇸
MDS Pharma Services, Phoenix, Arizona, United States
Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: ethinyl estradiol, norethindrone, VI-0521
- First Posted Date
- 2009-01-13
- Last Posted Date
- 2009-12-02
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 20
- Registration Number
- NCT00821496
- Locations
- 🇺🇸
MDS Pharma Services, Phoenix, Arizona, United States
Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2012-08-17
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 390
- Registration Number
- NCT00809471
- Locations
- 🇺🇸
Research Site, Spring, Texas, United States
A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.
Phase 2
Completed
- Conditions
- OverweightObesity
- Interventions
- First Posted Date
- 2008-12-10
- Last Posted Date
- 2013-09-13
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 80
- Registration Number
- NCT00806260
- Locations
- 🇺🇸
Research Site, Lincoln, Nebraska, United States
A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2012-09-10
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 676
- Registration Number
- NCT00796367
Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2012-07-11
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 646
- Registration Number
- NCT00790751
- Locations
- 🇺🇸
Research Site, Spring, Texas, United States
To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil
Phase 1
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- First Posted Date
- 2008-10-09
- Last Posted Date
- 2009-12-02
- Lead Sponsor
- VIVUS LLC
- Target Recruit Count
- 44
- Registration Number
- NCT00770042
- Locations
- 🇺🇸
Research Site, Lincoln, Nebraska, United States
© Copyright 2025. All Rights Reserved by MedPath